Putative mediator role of endothelin-1 in asthma and other lung diseases

Clinical and Experimental Pharmacology and Physiology

Volumn 26, Issue 2, 1999, Pages 168-171

  Hay, D W P ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Cndothelin receptor antagonists; Endothelin receptor subtypes; Endothelin 1; Pulmonary diseases

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN RECEPTOR;

ASTHMA; DRUG ANTAGONISM; HUMAN; LUNG DISEASE; METABOLISM; MOLECULAR MIMICRY; PATHOPHYSIOLOGY; PHYSIOLOGY; PULMONARY HYPERTENSION; REVIEW;

ASTHMA; ENDOTHELIN-1; HUMANS; HYPERTENSION, PULMONARY; LUNG DISEASES; MOLECULAR MIMICRY; RECEPTORS, ENDOTHELIN;

EID: 0033072844     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.1999.03009.x     Document Type: Conference Paper

References (35)

1. Musaki T, Yanagisawa M, Goto K. Physiology and pharmacology of endothelins. Med. Res. Rev. 1992; 12: 391-421.
2. Goldie RG, Knott PG, Carr MJ, Hay DWP, Henry P.I, The endothelins in the pulmonary system. Pulmon. Pharmacol. 1996; 9: 69-93.
3. Pons F, Touvay C, Lagente V, Mencia-Huerta JM, Braquet P. Involvement of a phoshoramidon-sensitive endopeptidase in the processing of big endothelin-1 in the guinea-pig. Eur. J. Pharmacol. 1992; 217: 65-70.
4. Sawamura T, Shinmi O, Kishi N et al. Characterization of phosphoramidon-sensitive metalloproteinases with endothelin-converting enzyme activity in porcine lung membrane. Biochim. Biophys. Acta 1993; 1161: 295-302.
5. Saleh D, Furukawa K, Tsao M-S et al. Elevated expression of endothelin-1 and endothelin-converting enzyme-1 in idiopathic pulmonary fibrosis: Possible involvement of proinflammatory cytokines. Am. J. Respir. Cell Mol. Biol. 1997; 16: 187-93.
6. Furukawa K, Saleh D, Bayan F et al. Co-expression of endothelin-1 and endothelin-converting enzyme-1 in patients with chronic rhinitis. Am. J. Respir. Cell Mol. Biol. 1996; 14; 248-53.
7. Giaid A, Polak JM, Gaitonde V et al. Distribution of endothelin-like immunoreactivity and mRNA in the developing and adult human lung. Am. J. Respir. Cell Mol. Biol. 1991; 4: 50-8.
8. Ehrenreich H, Anderson RW, Fox CH et al. Endothelins, peptides with potent vasoactive properties, are produced by human macrophages. J. Exp. Med. 1990; 172: 1741-8.
9. Endo T, Uchida Y, Matsumoto H et al. Regulation of endothelin-1 synthesis in cultured pig airway epithelial cells by various cytokines. Biochem. Biophys. Res. Commun. 1992; 186: 1594-9.
10. Hay DWP. Guinea-pig tracheal epithelium and endothelin. Eur. J. Pharmacol. 1989; 171: 241-5.
11. B receptors in rat. Biochem. Biophys. Res. Commun. 1994; 199; 1461-5.
12. Goldie RG, Henry PJ, Knott PG, Self GJ, Luttmann MA, Hay DWP. Endothelin-1 receptor density, distribution and function in human isolated asthmatic airways. Am. J. Respir. Crit. Care Med. 1995; 152: 1653-8.
13. Knott PG, D'Aprile AC, Henry PJ, Hay DWP, Goldie RG. Receptors tor endothelin-1 in asthmatic human peripheral lung. Br. J. Pharmacol. 1995; 114: 1-3.
14. Henry PJ, Rigby PJ, Self GJ, Preuss JM, Goldie RG. Relationship between endothelin-1 binding site densities and constrictor activities in human and animal airway smooth muscle. Br. J. Pharmacol. 1990; 100: 786-92.
15. Hay DWP, Hubbard WC, Undem BJ. Endothelin-induced contraction and mediator release in human bronchus. Br. J. Pharmacol. 1993; 110: 392-8.
16. B) receptor-activated potentiation of cholinergic nerve-mediated contraction in human bronchus. Br. J. Pharmacol. 1996; 118: 1873-4.
17. Brink C, Gillard V, Roubert P et al. Effects and specific binding sites of endothelin in human lung preparations. Pulmon. Pharmacol. 1991; 4: 54-9.
18. Tomlinson PR, Wilson JW, Stewart AG. Inhibition by salbutamol of the proliferation of human airway smooth muscle cells grown in culture. Br. J. Pharmacol. 1994; 111: 641-7.
19. Panettieri Jr RA, Goldie RG, Rigby PJ, Eszterhas AJ, Hay DWP. Endothelin-1-induced potentiation: an ETA receptor-mediated phenomenon. Dr. J. Pharmacol. 1996; 118: 191-7.
20. B receptor subtypes for antagonism of endothelin-1-induced contraction in human bronchus. Br. J. Pharmacol. 1996; 117: 995-9.
21. Chalmers GW, Little SA, Patel KR, Thompson NC. Endothelin-1-induced bronchoconstriction in asthma. Am. J Respir. Crit. Care Med. 1997; 156: 382-8.
22. Helset E, Sildnes T, Seljelid R, Konoski ZS. Endothelin-1 stimulates human monocytes in vitro to release TNF-α, 1L-1β and IL-6. Med. Inflamm. 1993; 2: 417-22.
23. Egger D, Geuenich S, Denzlinger C. et al. IL-4 renders mast cells functionally responsive to endothelin-1. J. Immunol. 1995; 154: 1830-7.
24. Fujitani Y, Trifilieff A, Tsuyuki S, Coyle AJ, Bertrand C. Endothelin receptor antagonists inhibit antigen-induced lung inflammation in mice. Am. J. Respir. Crit. Care Med. 1997; 155: 1890-4.
25. Power RE, Wharton J, Zhao Y, Bloom SR, Polak JM. Autoradiographic localization of endothelin-1 binding sites in the cardiovascular and respiratory systems. J. Cardiovasc. Pharmacol. 1989; 13 (Suppl. 5): S50-6.
26. A receptor antagonist, inhibits endothelin-1-mediated proliferation of human pulmonary artery smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 1993; 9: 429-33.
27. Mullol J, Chowdhury BA, White MV et al. Endothelin in human nasal mucosa. Am. J. Respir. Cell Mol Biol. 1993; 8: 393-402.
28. Wu T, Mullol J, Rieves RD et al. Endothelin-1 stimulates eicosanoid production in cultured human nasal mucosa. Am. J. Respir. Cell Mol. Biol. 1992; 6: 168-74.
29. Riccio MA, Reynolds CJ, Hay DWP, Proud D. Effects of intranasal administration of endothelin-1 to allergic and nonallergic individuals. Am. J. Respir. Crit. Care Med. 1995; 152: 1757-64.
30. Springall DR, Howarth PH, Counihan H, Djukanovic R, Holgate ST, Polak JM. Endothelin immunoreactivity of airway epithelium in asthmatic patients. Lancet 1991; 337; 697-701.
31. Redington AR, Springall DR, Ghatei MA et al. Endothelin in broncho-alveolar lavage fluid and its relation to airflow obstruction in asthma. Am. J. Respir. Crit. Care Med. 1995; 151: 1034-9.
32. Chalmers GW, Thomson L, Macleod KJ et al. Endothelin-1 levels in induced sputum samples from asthmatic and normal subjects. Thorax 1997; 52: 625-7.
33. Allen SW, Chatfield BA, Koppenhafer SA, Schaffer MS, Wolfe RR, Abman SH. Circulating immunoreactive endothelin-1 in children with pulmonary hypertension. Association with acute hypoxic pulmonary vasoreactivity. Am. Rev. Respir. Dis. 1993; 148: 519-22.
34. Cernacek P, Stewart DJ. Immunoreactive endothelin in human plasma: Marked elevations in patients with cardiogenic shock. Biochem. Biophys. Res. Commun. 1989; 161: 562-7.
35. Oparil S, Chen SJ, Meng QC, Elton TS, Yano M, Chen YF. Endothelin-A receptor antagonist prevents acute hypoxia-induced pulmonary hypertension in the rat. Am. J. Physiol. 1995; 12: L95-100.